Stem Cells: Cellular & Drug Therapies -- Volume 2
Autor Philippe Taupinen Limba Engleză Hardback – mar 2014
| Toate formatele și edițiile | Preț | Express |
|---|---|---|
| Hardback (2) | 569.86 lei 3-5 săpt. | |
| Nova Science Publishers Inc – mar 2009 | 569.86 lei 3-5 săpt. | |
| Nova Science Publishers Inc – mar 2014 | 1112.34 lei 3-5 săpt. |
Preț: 1112.34 lei
Preț vechi: 1603.49 lei
-31%
Puncte Express: 1669
Preț estimativ în valută:
196.79€ • 232.02$ • 170.92£
196.79€ • 232.02$ • 170.92£
Carte disponibilă
Livrare economică 02-16 martie
Specificații
ISBN-13: 9781629487786
ISBN-10: 1629487783
Pagini: 360
Dimensiuni: 180 x 260 x 17 mm
Greutate: 0.57 kg
Editura: Nova Science Publishers Inc
Colecția Nova Science Publishers, Inc (US)
Locul publicării:United States
ISBN-10: 1629487783
Pagini: 360
Dimensiuni: 180 x 260 x 17 mm
Greutate: 0.57 kg
Editura: Nova Science Publishers Inc
Colecția Nova Science Publishers, Inc (US)
Locul publicării:United States
Cuprins
Introduction; Adult Neurogenesis in Etiology & Pathogenesis of Alzheimers Disease; Adult Neurogenesis & Aneuploidy in Etiology, Pathogenesis & Pathology of Alzheimers Disease; Adult Neurogenesis, Neural Stem Cells & Alzheimers Disease: Developments, Limitations, Problems & Promises; Oxidative Stress in Adult Neurogenesis & in the Pathogenesis of Alzheimer's Disease; Adult Neurogenesis, Neuroinflamation, & Therapeutic Potential of Adult Neural Stem Cells; Adult Neurogenesis & Drug Therapy; Neurogenesis & the Effect of Antidepressants; Neurogenic Drugs & Compounds to Treat CNS Diseases & Disorders; Patent Evaluation. Thirteen Compounds Promoting Oligodendrocyte Progenitor Cell Differentiation & Remyelination for Treating Multiple Sclerosis: Wo2010054307; Patent Evaluation. Antibodies against CD20 (Rituximab) for Treating Multiple Sclerosis: US20100233121; Umbilical Cord Blood & Alpha-3 Fucosyl Transferase-Treated Haematopoietic Stem Cells for Transplantation; Patent Evaluation. Cell Lines Expressing Mutant FX Proteins to Generate Proteins with Reduced Rate of Fucosylation: Wo2010/141478; Patent Evaluation. Modulation of GDP-Fucose Level for Generating Proteins with Reduced Rate of Fucosylation (Wo2010141855); Patent Evaluation. Chimeric Proteins Comprising the Constant Region of Immunoglobulins for Treating Haemophilia B (WO2005001025); Patent Evaluation Parthenogenetically Activated Human Oocytes & Parthenogenetic Embryonic Stem Cells: US20100233143; Tuberous Sclerosis Complex: A Paradigm for Studying Adult Neurogenesis & Brain Tumors; Adult Neurogenesis in Alzheimers Disease & Therapies; Indacaterol for the Treatment of Patients with Moderate-to-Severe COPD; Conclusions; Index.